Ambros Therapeutics is a biotechnology company focused on developing innovative therapeutic solutions for serious diseases. Leveraging cutting‑edge research in molecular biology and immunology, Ambros aims to bring novel treatments from discovery through clinical development to patients in need. The company emphasizes robust scientific collaboration, advanced platform technologies, and a commitment to addressing unmet medical needs across oncology, rare diseases, and other critical therapeutic areas.
Ambros Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Innovation, and Research.
Regulatory Posture applies to this provider. Its tags matched the
Horizontal (data, software, accessibility, platform) regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: ambros-therapeutics
name: Ambros Therapeutics
description: Ambros Therapeutics is a biotechnology company focused on developing innovative therapeutic solutions for serious
diseases. Leveraging cutting‑edge research in molecular biology and immunology, Ambros aims to bring novel treatments from
discovery through clinical development to patients in need. The company emphasizes robust scientific collaboration, advanced
platform technologies, and a commitment to addressing unmet medical needs across oncology, rare diseases, and other critical
therapeutic areas.
url: https://raw.githubusercontent.com/api-evangelist/ambros-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-09-24 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-09-24'
modified: '2026-09-24'
tags:
- Company
- Biotechnology
- Therapeutics
- Innovation
- Research
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
image: https://ambrostherapeutics.com/wp-content/themes/ambros_theme/assets/images/logo.png
common:
- type: Hosts
url: hosts/ambros-therapeutics-hosts.yml
- type: DomainSecurity
url: security/ambros-therapeutics-domain-security.yml
- type: Website
url: https://ambrostherapeutics.com/
apis: []
x-coverage:
state: none
reason: no-developer-program
method: derived
generated: '2026-09-24'
generator: derive-coverage.py (pre-flight evidence)
detail: the company publishes no developer documentation host and no machine-readable contract on its own domain
x-enrichment:
date: '2026-09-24'
status: enriched
artifacts_added: 4
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →